Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
11 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2024
12 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Amany Mohammed Abdel Moatamed 2024
13 The transcription factor ZEB-1 conveys chemoresistance in breast cancer Department of Medical Oncology Samar Abotaleb Mahmou 2024
14 Role of Irreversible Electroporation in Solid Abdominal Tumors Management Department of Radiology Prof. Amro Farouk ِAhmedMourad 2024
15 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Dr. Badawy, Mohammed Ahmed Mohammed 2023
16 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2023
17 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Department of Medical Oncology Amany Nasr Ahmed Mohammed Elemary 2023
18 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Amany Mohammed Abdel Moatamed 2023
19 18F-FDG gallbladder uptake: observation from a total-body PET/CT scanner Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2023
20 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Dr. Ahmed Refaat Abdel Zaher Mubarak 2023